WuXi Biologics announces new discovery, development and manufacturing site in China

By Flora Southey

- Last updated on GMT

WuXi Biologics has broken ground on its Biologics Innovation Center in Shanghai, China
WuXi Biologics has broken ground on its Biologics Innovation Center in Shanghai, China

Related tags Wuxi biologics CDMO China

The CDMO has broken ground on its 1.6 million-square-foot Biologics Innovation Center in Shanghai.

Contract development and manufacturing organisation (CDMO) WuXi Biologics has announced plans to build its Biologics Innovation Center in the Fengxian district of Shanghai.

The 1.6 million-square-foot centre will house discovery and development laboratories, alongside good manufacturing practice (GMP) capabilities for commercial production.

WuXi Biologics' Innovation Center, Shanghai, China

Laboratory facilities are due to open in 2019, with GMP manufacturing expected to launch in 2021. The site will accommodate more than 3,000 scientists recruited predominantly from China.

According to CEO Chris Chen, the build responds to growing demand for the manufacture of large molecule drugs: “We have a portfolio of 187 biologics [that require] manufacturing and the number of projects is still growing,” ​we were told. The Innovation Center brings “everything in one place,” ​he continued.

The firm did not disclose the cost of the build, nor provide specifics on the site’s “significant”​ bioreactor capacity.

The announcement adds to the Chinese CDMO’s growing site network, which also includes plans for international expansion in Ireland​, Singapore​, and the US​.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Related suppliers

Follow us

Webinars

Headlines